[MRANTI Webinar] HealthTech Series: Building Scalable EV Research & Manufacturing Workflows

Extracellular Vesicles (EVs) are emerging as a transformative platform in biotechnology, with growing applications in regenerative medicine, diagnostics, and therapeutic development. As research and commercial interest in EV-based technologies continue to accelerate, there is an increasing need to develop scalable and reproducible workflows that can support the translation of laboratory discoveries into real-world healthcare solutions.

This session will provide participants with an introduction to Extracellular Vesicles (EVs) and explore how advancements in EV technologies are driving innovation across biotechnology and healthcare. Participants will gain practical insights into building an end-to-end EV bioprocessing workflow, from research and discovery through to pilot-scale production and GMP-ready manufacturing. The session will also cover the key stages of EV development, including isolation, purification, characterisation, process optimisation, and scale-up strategies required to support clinical and commercial applications.

This webinar is part of MRANTI's broader HealthTech Series, designed to equip innovators, researchers, startups, and industry stakeholders with the knowledge, skills, and ecosystem connections needed to advance healthcare innovation. The insights gained from this session will provide participants with a deeper understanding of EV technologies and the pathways required to translate research into scalable, GMP-ready solutions, supporting future innovation, commercialisation, and growth within the biotechnology and healthcare sectors.

Key Takeaways

• Gain a deeper understanding of extracellular vesicles (EVs), their emerging role in regenerative medicine, diagnostics, and therapeutic development, and the growing opportunities they present within the biotechnology and healthcare sectors.
• Explore how EV innovations are progressing from research and laboratory discovery towards translational, clinical, and commercial applications, and discover the key factors that enable successful technology development and adoption.
• Learn the essential components of an end-to-end EV bioprocessing workflow, including isolation, purification, characterisation, process optimisation, and scale-up strategies required to support reproducible, high-quality, and GMP-ready manufacturing.

Why Join Us?

Extracellular Vesicles (EVs) are emerging as a promising frontier in biotechnology, with growing applications in regenerative medicine, diagnostics, and therapeutic development. Understanding how EV innovations progress from research to scalable and GMP-ready manufacturing is essential for researchers, innovators, startups, and industry professionals seeking to advance next-generation healthcare solutions.

In this session, you will:

• Gain a practical introduction to extracellular vesicles (EVs), including their biological roles and potential as biomarkers and therapeutic candidates
• Compare common EV isolation technologies and understand their advantages, limitations, and suitability for different research and translational applications
• Explore key considerations and challenges for translating EV research into clinical trials and GMP-scale manufacturing
• Discover workflow solutions for EV bioprocessing and high-throughput sample processing that support high EV recovery while maintaining EV purity and quality

Join us to gain practical insights, expand your network, and explore how EV technologies are shaping the future of healthcare innovation and commercialisation.

Register now to secure your place.